Department of Pathology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, 570311, China.
BMC Infect Dis. 2024 Nov 14;24(1):1298. doi: 10.1186/s12879-024-10193-7.
Extrapulmonary tuberculosis (TB) is a relatively rare form of tuberculosis infection, accounting for approximately 15% of all tuberculosis infections. Lymph nodes are the most commonly affected sites, while involvement of the parotid gland is extremely rare.
We present the case of a 65-year-old male patient with a one-month history of a left parotid mass. The patient has a history of diabetes and long-term smoking, and a chest X-ray revealed secondary fibrotic pulmonary tuberculosis, while sputum smears were culture-negative for Mycobacterium tuberculosis (Mtb). The parotid mass was surgically removed and subjected to routine HE staining, acid-fast staining, and PCR molecular testing for Mtb. The final diagnosis was Warthin's tumor of the parotid gland with concomitant tuberculosis. One month after removal of the parotid mass, the patient's chest CT showed cavitary tuberculosis. Subsequently, the patient received anti-tuberculosis treatment; however, due to severe gastrointestinal adverse effects, the patient stopped the medication in less than a month and did not receive regular treatment. Four months after stopping the medication, the patient's pulmonary tuberculosis progressed and worsened.
Combined tuberculosis in Warthin's tumor is extremely rare, with only 14 cases reported to date. However, the specific pathogenesis of this condition is not yet fully understood, and the preliminary treatment and prognosis have not been conclusively determined. Early diagnosis of tuberculosis, standardized and effective use of anti-tuberculosis drugs, and personalized treatment are crucial in the management of tuberculosis. We have reviewed the treatment progress of this rare disease and analyzed the potential pathogenesis of the condition. Furthermore, we have summarized the current understanding of the pathogenesis of tuberculosis, drug resistance mechanisms, and the latest treatment advances. These studies have important clinical implications for better understanding and treating extrapulmonary tuberculosis and tuberculosis within Warthin's tumor of the parotid gland. This comprehensive analysis sheds light on the complexities of tuberculosis and provides valuable insights for improved management and care of affected individuals.
肺外结核(TB)是一种相对罕见的结核病感染形式,约占所有结核病感染的 15%。淋巴结是最常受影响的部位,而腮腺受累则极为罕见。
我们报告了一例 65 岁男性患者,其左侧腮腺肿块病史为一个月。患者有糖尿病和长期吸烟史,胸部 X 光片显示为继发性纤维化肺结核,而痰涂片培养结核分枝杆菌(Mtb)为阴性。腮腺肿块被手术切除,并进行常规 HE 染色、抗酸染色和 Mtb PCR 分子检测。最终诊断为腮腺沃辛瘤合并结核。腮腺肿块切除一个月后,患者的胸部 CT 显示有空洞性肺结核。随后,患者接受了抗结核治疗;然而,由于严重的胃肠道不良反应,患者在不到一个月的时间内停止了用药,并且没有接受常规治疗。停药四个月后,患者的肺结核进展并恶化。
沃辛瘤合并结核极为罕见,迄今为止仅报告了 14 例。然而,这种情况的确切发病机制尚不完全清楚,初步治疗和预后也没有得到确定。早期诊断结核病、规范和有效地使用抗结核药物以及个性化治疗对于结核病的管理至关重要。我们回顾了这种罕见疾病的治疗进展,并分析了该疾病的潜在发病机制。此外,我们总结了目前对结核病发病机制、耐药机制和最新治疗进展的认识。这些研究对更好地理解和治疗肺外结核病以及腮腺沃辛瘤内的结核病具有重要的临床意义。这种综合分析揭示了结核病的复杂性,并为改善受影响个体的管理和护理提供了有价值的见解。